CAS: 1628317-18-9
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | MI-463 REF: AN-AG00AR6RCAS: 1628317-18-9 | 99% | To inquire | Tue 21 May 24 |
 | MI-463 REF: TM-TQ0058CAS: 1628317-18-9 | 100% | 59.00 €~500.00 € | Tue 28 May 24 |
 | MI-463 REF: 3D-DQC31718CAS: 1628317-18-9 | Min. 95% | To inquire | Mon 01 Jul 24 |
Ref: AN-AG00AR6R
| 5mg | 231.00 € | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 May 2024
MI-463
CAS:1628317-18-9
MI-463 is a potent and orally bioavailable inhibitor of the menin-mLL interaction (IC50: 15.3 nM).
Formula:
C24H23F3N6S
Purity:
100%
Color and Shape:
Solid
Molecular weight:
484.54
Ref: TM-TQ0058
| 1mg | 59.00 € | |
| 5mg | 94.00 € | |
| 10mg | 149.00 € | |
| 25mg | 260.00 € | |
| 50mg | 371.00 € | |
| 100mg | 500.00 € | |
| 1ml*10 (DMSO) | 95.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
MI-463
CAS:1628317-18-9
MI-463 is a drug that has been repurposed to treat cancer. It is a fatty …
Formula:
C24H23F3N6S
Purity:
Min. 95%
Molecular weight:
484.54 g/mol
Ref: 3D-DQC31718
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Estimated delivery in United States, on Monday 1 Jul 2024
